Celularity
CELU
24 hedge funds and large institutions have $85.6M invested in Celularity in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.
2,663% more call options, than puts
Call options by funds: $6.66M | Put options by funds: $241K
917% more capital invested
Capital invested by funds: $8.42M → $85.6M (+$77.2M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
14% more funds holding
Funds holding: 21 → 24 (+3)
1.26% more ownership
Funds ownership: 0.1% → 1.35% (+1.3%)
Top Buyers
Top Sellers
| 1 |
HF
HRT Financial
New York
|
-$265K |
| 2 |
Jane Street
New York
|
-$196K |
| 3 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$142K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$136K |
| 5 |
Millennium Management
New York
|
-$109K |
CELU Hedge Fund Activity: Q4 2021 in Review
24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2021, worth a combined $85.6M — up 917% from $8.42M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CELU positions and 8 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Starr International Company, opening a new position worth an estimated $55.2M. The largest seller was HRT Financial, cutting an estimated $265K.
- 24 institutional investors held Celularity (CELU) as of Q4 2021, up from 21 in Q3 2021.
- Funds reported $85.6M of Celularity stock for Q4 2021, up 917% quarter-over-quarter.
- 11 funds opened new Celularity positions in Q4 2021 and 8 closed out, a net change of +3 holders.
- The largest Celularity buyer in Q4 2021 was Starr International Company, an estimated $55.2M added.
- The largest Celularity seller in Q4 2021 was HRT Financial, an estimated $265K sold.
Based on aggregated 13F filings for Q4 2021.